RBC Life Sciences Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
RBCL has 42.21 million shares outstanding.
| Current Share Class | 42.21M |
| Shares Outstanding | 42.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16
| Current Ratio | 2.16 |
| Quick Ratio | 0.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.24 |
Financial Efficiency
Return on equity (ROE) is -6.77% and return on invested capital (ROIC) is -16.33%.
| Return on Equity (ROE) | -6.77% |
| Return on Assets (ROA) | -10.03% |
| Return on Invested Capital (ROIC) | -16.33% |
| Return on Capital Employed (ROCE) | -27.02% |
| Revenue Per Employee | 270,964 |
| Profits Per Employee | -6,287 |
| Employee Count | 89 |
| Asset Turnover | 1.67 |
| Inventory Turnover | 2.08 |
Taxes
| Income Tax | -112,507 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -15.12 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 35.32 |
| Average Volume (20 Days) | 2,634 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, RBCL had revenue of 24.12 million and -559,508 in losses. Loss per share was -0.25.
| Revenue | 24.12M |
| Gross Profit | 13.72M |
| Operating Income | -2.32M |
| Pretax Income | -672,015 |
| Net Income | -559,508 |
| EBITDA | -1.79M |
| EBIT | -2.32M |
| Loss Per Share | -0.25 |
Balance Sheet
The company has 2.09 million in cash and n/a in debt, giving a net cash position of 2.09 million or 0.05 per share.
| Cash & Cash Equivalents | 2.09M |
| Total Debt | n/a |
| Net Cash | 2.09M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 8.04M |
| Book Value Per Share | 3.63 |
| Working Capital | 4.95M |
Cash Flow
In the last 12 months, operating cash flow was -2.90 million and capital expenditures -383,992, giving a free cash flow of -3.29 million.
| Operating Cash Flow | -2.90M |
| Capital Expenditures | -383,992 |
| Free Cash Flow | -3.29M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 56.90%, with operating and profit margins of -9.60% and -2.32%.
| Gross Margin | 56.90% |
| Operating Margin | -9.60% |
| Pretax Margin | -2.79% |
| Profit Margin | -2.32% |
| EBITDA Margin | -7.44% |
| EBIT Margin | -9.60% |
| FCF Margin | n/a |
Dividends & Yields
RBCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | n/a |
| Earnings Yield | -13,255.34% |
| FCF Yield | -77,872.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2013. It was a reverse split with a ratio of 0.1.
| Last Split Date | Aug 12, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
RBCL has an Altman Z-Score of 1.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.4 |
| Piotroski F-Score | 3 |